DCT

1:20-md-02930

In re: Entresto (Sacubitril/Valsartan) Patent Litigation

General

Filed

03/27/20

Cause of ActionPatent Infringement

SectorBiotech

Status

Closed (07/08/24)

Patent Owner

Operating Company (W)

PACER

Nature of Suit835 ANDA

Appeals

Judge	Period	PO Win Rate
Richard G. Andrews	03/15/22 - 01/15/25	36%
Leonard P. Stark	03/31/20 - 03/15/22	41%

Plaintiff

Party

Name	Ratings
Novartis Pharmaceuticals Corp	L4 A

No Parties

Attorney

Name	Ratings
McCarter & English LLP	L5 A
Daniel M. Silver	L5 A
Alexandra M. Joyce	L5 B
Fitzpatrick Cella Harper & Scinto	L5 A
Christopher E. Loh	L3 A
Venable LLP	L5 A
Nicholas N. Kallas	L2 C
Christina Schwarz	L2 D
Shannon Clark	L1 B
Susanne Flanders	L1 B
Jared Stringham	L1 B
Gregory J. Manas	L1 B
Laura Fishwick	L1 C

No Attorneys

Defendant

Party

Name	Ratings
Nanjing Noratech Pharmaceutical Co Ltd	L1 D
Gerbera Therapeutics Inc	-- -- --

No Parties

Attorney

Name	Ratings
Husch Blackwell LLP	L4 B
Don J. Mizerk	L4 E
Thomas P. Heneghan	L2 A
Avery Hitchcock	-- -- --
Heyman Enerio Gattuso & Hirzel LLPLocal	L3 E
Dominick T. Gattuso	L5 E
Denise S. Kraft	-- -- --

No Attorneys